FINWIRES · TerminalLIVE
FINWIRES

Truist Raises Price Target on Teva Pharmaceutical Industries to $45 From $42, Keeps Buy Rating

By

Teva Pharmaceutical Industries (TEVA) has an average rating of buy and mean price target of $41.89 according to analysts polled by FactSet.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Price: $35.09, Change: $-0.29, Percent Change: -0.82%

Related Articles